Fenwick & West represented Shockwave Medical, Inc. in the transaction.Shockwave Medical, Inc. (Nasdaq: SWAV) announced its $750 million offering of 1.00% convertible senior notes due 2028 in…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
